Utilizing Chlamydia trachomatis IgG serology with HSG to diagnose tuboperitoneal-factor infertility.
To evaluate if Chlamydia trachomatis IgG serology combined with hysterosalpingography can make it easier to detect tuboperitoneal factor infertility, we conducted a chart review of 76 consecutive patients at an infertility practice at West Virginia University from 1999-2001. We checked the charts for results of Chlamydia trachomatis IgG serology, Hysterosalpingography (HSG) and laparoscopy. Results of these tests were reviewed along with age, parity, previous reproductive tract disease surgery and duration of infertility. Complete data was found on 32 of the 76 patients. Chlamydia serology in conjunction with the HSG had a sensitivity of 80% for tuboperitoneal factor (tubal obstruction or pelvic adhesions), and a specificity of 82.3%. The positive predictive value was 80% and the negative predictive value was 82%. Since Chlamdia trachomatis IgG serologic testing is non-invasive and relatively inexpensive, we recommend combining it with hysterosalpingography as an infertility work-up. More invasive testing such as laparoscopy may be postponed or completely eliminated.
D002692:Chlamydia trachomatis / Q000821:virology*; D005260:Female; D006801:Humans; D007047:Hysterosalpingography / Q000379:methods; D007074:Immunoglobulin G / Q000097:blood*; D007247:Infertility, Female / Q000175:diagnosis*; D010535:Laparoscopy; D008875:Middle Aged; D010865:Pilot Projects; D012189:Retrospective Studies; D012488:Salpingitis / Q000150:complications
D007074:Immunoglobulin G